Parthenon LLC Abb Vie Inc. Transaction History

Parthenon LLC

$774 Million
Q2 2024

A detailed history of Parthenon LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Parthenon LLC holds 23,688 shares of ABBV stock, worth $4.67 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

23,688

Previous 23,688 -0.0%

Holding current value

$4.67 Million

Previous $4.31 Million 5.82%

% of portfolio

0.52%

Previous 0.56%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $40,434 - $46,071	253 Added 1.08%	23,688 $4.31 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $155,625 - $175,271	-1,131 Reduced 4.6%	23,435 $3.63 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $76,064 - $87,600	-526 Reduced 2.1%	24,566 $3.92 Million
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $163,199 - $187,178	-1,216 Reduced 4.62%	25,092 $3.37 Million
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $144,501 - $183,708	-1,050 Reduced 3.84%	26,308 $4.03 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $6,598 - $8,187	50 Added 0.18%	27,358 $4.44 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $215,140 - $244,217	-2,022 Reduced 6.89%	27,308 $2.95 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $233,776 - $260,440	2,222 Added 8.2%	29,330 $3.3 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $252,476 - $277,946	2,468 Added 10.02%	27,108 $2.93 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $198,649 - $268,197	-2,468 Reduced 9.1%	24,640 $2.64 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $2,319 - $2,722	-27 Reduced 0.1%	27,108 $2.37 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $25,019 - $33,479	341 Added 1.27%	27,135 $2.66 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $70,111 - $106,297	-1,087 Reduced 3.9%	26,794 $2.04 Million
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $30,294 - $37,905	-420 Reduced 1.48%	27,881 $2.47 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $4,849 - $5,830	-77 Reduced 0.27%	28,301 $2.14 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $79,951 - $98,602	-1,027 Reduced 3.49%	28,378 $2.62 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $371,999 - $413,546	-4,184 Reduced 12.46%	29,405 $2.78 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $230,025 - $308,025	-2,500 Reduced 6.93%	33,589 $3.18 Million
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $345,701 - $379,090	-3,860 Reduced 9.66%	36,089 $3.49 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $2.79 Million - $3.56 Million	39,949	39,949 $3.55 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parthenon LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parthenon LLC with notifications on news.

Account